Correlation Between VTv Therapeutics and Scpharmaceuticals
Can any of the company-specific risk be diversified away by investing in both VTv Therapeutics and Scpharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VTv Therapeutics and Scpharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between vTv Therapeutics and Scpharmaceuticals, you can compare the effects of market volatilities on VTv Therapeutics and Scpharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VTv Therapeutics with a short position of Scpharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of VTv Therapeutics and Scpharmaceuticals.
Diversification Opportunities for VTv Therapeutics and Scpharmaceuticals
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between VTv and Scpharmaceuticals is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding vTv Therapeutics and Scpharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scpharmaceuticals and VTv Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on vTv Therapeutics are associated (or correlated) with Scpharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scpharmaceuticals has no effect on the direction of VTv Therapeutics i.e., VTv Therapeutics and Scpharmaceuticals go up and down completely randomly.
Pair Corralation between VTv Therapeutics and Scpharmaceuticals
Given the investment horizon of 90 days vTv Therapeutics is expected to generate 1.37 times more return on investment than Scpharmaceuticals. However, VTv Therapeutics is 1.37 times more volatile than Scpharmaceuticals. It trades about 0.13 of its potential returns per unit of risk. Scpharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest 1,357 in vTv Therapeutics on November 2, 2024 and sell it today you would earn a total of 109.00 from holding vTv Therapeutics or generate 8.03% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
vTv Therapeutics vs. Scpharmaceuticals
Performance |
| Timeline |
| vTv Therapeutics |
| Scpharmaceuticals |
VTv Therapeutics and Scpharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with VTv Therapeutics and Scpharmaceuticals
The main advantage of trading using opposite VTv Therapeutics and Scpharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VTv Therapeutics position performs unexpectedly, Scpharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scpharmaceuticals will offset losses from the drop in Scpharmaceuticals' long position.| VTv Therapeutics vs. Zura Bio Limited | VTv Therapeutics vs. Phio Pharmaceuticals Corp | VTv Therapeutics vs. Immix Biopharma | VTv Therapeutics vs. NovaBay Pharmaceuticals |
| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets |